CD44 and breast cancer: In BC, the proteins circulating galectin-3 and CD44-mediated signaling pathways, as well as cancer-associated mucin1 (MUC1), interact altogether, inhibiting anoikis of clusters in the circulation, promoting their aggregation and enhancing their seeding to distant organs [22, 89].